Section Arrow
VRNA.NASDAQ
- Verona Pharma plc
Quotes are at least 15-min delayed:2024/12/23 22:23 EST
Last
 45.28
+3.26 (+7.76%)
Day High 
45.98 
Prev. Close
42.02 
1-M High
43.73 
Volume 
1.11M 
Bid
45
Ask
45.98
Day Low
42.07 
Open
42.07 
1-M Low
37.67 
Market Cap 
3.44B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 40.79 
20-SMA 40.2 
50-SMA 37.57 
52-W High 45.98 
52-W Low 11.39 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.00/-0.80
Enterprise Value
3.49B
Balance Sheet
Book Value Per Share
1.59
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.01
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.4031-0.2085-34.09%-- 
RAPTRAPT Therapeutics1.74+0.9146+110.81%-- 
TRAWTraws Pharma Inc12.57+7.55+150.40%-- 
CEROCERo Therapeutics Holdings0.0505-0.0056-9.98%-- 
RXRXRecursion Pharmaceuticals6.99+0.96+15.92%-- 
Quotes are at least 15-min delayed:2024/12/23 22:23 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.